Biotech News
Allogene Therapeutics Announces Pricing of Public Offering of Common Stock
ir.allogene.com2026-05-06 14:55 EST
SOUTH SAN FRANCISCO, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO) today announced the pricing of an underwritten public offering of 87,500,000 shares of its common stock at a price to the public of $2.00 per share.